Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioExx Specialty Proteins Ltd BIXZF

"Bioexx Specialty Proteins Inc is engaged in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials. The company's primary focus is on the production of proteins from canola and other oilseed feedstocks. Its products include Isolexx, a protein isolate for use in bakery products, meat products, vegetarian food products and meat analogues, and nutritional and protein bars, drinks, and supplements;


GREY:BIXZF - Post by User

Comment by Foodhawkon Jul 24, 2013 6:40am
329 Views
Post# 21626504

RE:RE:RE:EFSA 54th Plenary Session of NDA Panel

RE:RE:RE:EFSA 54th Plenary Session of NDA Panelapparently it was not adopted, but postponed. we don't know the reason until the minutes are publised in October. Good thing:  if the EFSA had reasoned safety concerns, they would have already issued a negative statement without any hesitation and consideration about the impact it would have on BXI (the EFSA could not care less about a little Canadian *****ty penny stock, and even less it cares for shareholders like 1230 racing and others.). The impact of a negative EFSA opinion on BXI would mean NO deal with a European partner and probably no deal at all. My view: there small issues, maybe even  only formal or some original documents missing (certificates of analysis, or information BXI  possessed but did not submit because Helm AG/Bioresco did not consider it as needed.) Don't expect anything from this European Agency during the summer. my best guess: it will be positibe for BXI but soonest in September, more likely in October.
<< Previous
Bullboard Posts
Next >>